Memantine does not show intracellular block of the NMDA receptor channel
- PMID: 18456253
- DOI: 10.1016/j.ejphar.2008.03.053
Memantine does not show intracellular block of the NMDA receptor channel
Abstract
Mg2+ is known to gain access to the NMDA receptor channel from both the extra- and intracellular compartments. Memantine, being an amphiphilic substance, reaches intracellular concentrations of approximately 30 microM, which are much higher than therapeutic extracellular concentrations ( approximately 1 microM). We therefore investigated whether memantine can also block the NMDA receptor channel from the intracellular compartment. NR1a/NR2A receptors were expressed in Xenopus oocytes and in classical two electrode voltage-clamp recordings, voltage-ramps from -100 to +100 mV confirmed moderate inward rectification of NR1a/NR2A receptor control responses at positive membrane potentials above +40 mV. Patch clamp recordings from these same cells (applying 100 microM glutamate and 1 mM Mg2+) revealed similar rectification at positive potentials in cell-attached mode which disappeared after pulling an inside-out patch. Application of 1 mM Mg2+ to the intracellular side of the receptor re-introduced the rectification seen in cell-attached mode, and 5 mM Mg2+ produced much more pronounced block. In contrast, 30 microM memantine was completely unable to block the NMDA receptor from the intracellular compartment. In conclusion, intracellular block of the NMDA receptor, as reported for Mg2+, is not of significance for the therapeutic effects of memantine.
Similar articles
-
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.Neuropharmacology. 2009 Apr;56(5):866-75. doi: 10.1016/j.neuropharm.2009.01.012. Epub 2009 Jan 21. Neuropharmacology. 2009. PMID: 19371579
-
Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.Neuropharmacology. 2007 Sep;53(3):415-20. doi: 10.1016/j.neuropharm.2007.05.022. Epub 2007 Jun 7. Neuropharmacology. 2007. PMID: 17632186
-
In vitro galantamine-memantine co-application: mechanism of beneficial action.Neuropharmacology. 2006 Dec;51(7-8):1181-91. doi: 10.1016/j.neuropharm.2006.08.007. Epub 2006 Sep 29. Neuropharmacology. 2006. PMID: 17011596
-
Mechanism of action of memantine.Curr Opin Pharmacol. 2006 Feb;6(1):61-7. doi: 10.1016/j.coph.2005.09.007. Epub 2005 Dec 20. Curr Opin Pharmacol. 2006. PMID: 16368266 Review.
-
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization.Amino Acids. 2000;19(1):167-72. Amino Acids. 2000. PMID: 11026485 Review.
Cited by
-
Effect of memantine on expression of Bace1-as and Bace1 genes in STZ-induced Alzheimeric rats.Mol Biol Rep. 2020 Aug;47(8):5737-5745. doi: 10.1007/s11033-020-05629-7. Epub 2020 Jul 9. Mol Biol Rep. 2020. PMID: 32648077
-
Functional architecture of olfactory ionotropic glutamate receptors.Neuron. 2011 Jan 13;69(1):44-60. doi: 10.1016/j.neuron.2010.11.042. Neuron. 2011. PMID: 21220098 Free PMC article.
-
Key binding interactions for memantine in the NMDA receptor.ACS Chem Neurosci. 2013 Feb 20;4(2):255-60. doi: 10.1021/cn300180a. Epub 2012 Dec 7. ACS Chem Neurosci. 2013. PMID: 23421676 Free PMC article.
-
Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons.Cell Mol Neurobiol. 2009 Dec;29(8):1233-44. doi: 10.1007/s10571-009-9419-x. Cell Mol Neurobiol. 2009. PMID: 19499323 Free PMC article.
-
Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection.PLoS One. 2013 May 31;8(5):e64894. doi: 10.1371/journal.pone.0064894. Print 2013. PLoS One. 2013. PMID: 23741413 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources